ALX Oncology Holdings Inc
ALXO
NASDAQ
Biotechnology
$1.96
USD
+0.02 (+1.03%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $272.41M
Volume 584.1K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SRZN | Surrozen Inc | $294.90M | - | -35.6% | - | |
IMRX | Immuneering Corp | $293.08M | - | - | - | |
ALXO | ALX Oncology Holdings Inc | $284.85M | - | - | - | |
ELDN | Eledon Pharmaceuticals Inc | $284.05M | - | - | - | |
ANIK | Anika Therapeutics Inc | $279.30M | - | -2.5% | - | |
TRDA | Entrada Therapeutics Inc | $270.61M | - | -94.1% | - | |
RNAC | Cartesian Therapeutics Inc | $262.01M | - | -94.9% | - | |
ZSQR | Z Squared Inc (Delaware) | $215.68M | - | +2149.0% | - |
Top Peer by Growth
Z Squared Inc (Delaware)
+2149.0% YoY Revenue
Best 1-Year Return
ALX Oncology Holdings Inc
+226.8% Return